NICORANDIL IMPROVE PROGNOSIS OF CARDIAC ARREST PATIENT: A LARGE-SCALE MEDICAL INFORMATION ANALYSIS

• At: AbuDhabi (United Arab Emirates) (2019)
• Type: Poster
• Poster code: POS-TRI-003
• By: NIIMURA, Takahiro (Tokushima University Graduate School of Biomedical Sciences, Department of Clinical Pharmacology and Therapeutics, Japan)
• Co-author(s): Takahiro Niimura: Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
  Yoshito Zamami: Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan;Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan
  Yuki Izawa-Ishizawa: AWA Support Center, Tokushima University, Tokushima, Japan
  Mitsuhiro Goda : Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan
  Kenshi Takechi: Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan
  Masayuki Chuma: Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan
  Keijo Fukushima: Department of Pharmacology for Life Sciences, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
  Yuya Horinouchi: Department of Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan
  Yasumasa Ikeda: Department of Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan
  Hiromichi Fujino: Department of Pharmacology for Life Sciences, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
  Koichiro Tsuchiya: Department of Medical Pharmacology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
  Keisuke Ishizawa: Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan;Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan
  
• Abstract:

  Background

  The survival rate of patients with cardiac arrest in Japan is around 10%. Because the main cause of poor survival prognosis is encephalopathy, development of a therapeutic drug for improving brain damage is desired. Nicorandil, a drug for the treatment of angina pectoris, has been reported to have a neuroprotective effect, but its effect ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login